Farah Hossain

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.7K citations

Medicine, Hematology, Oncology +17

CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

Deepu Madduri, Jesús G. Berdeja, Saad Z. Usmani et al. · Blood · 2020 · 94 citations

Medicine, Hematology, Oncology +16

Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study

Mrinalini Das, T. N. Mathur, Shilpa Ravi et al. · PLoS ONE · 2021 · 38 citations · Full text

Public Health, Child Health, Pediatrics +12

One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India

Mrinalini Das, Alpa Dalal, Chinmay Laxmeshwar et al. · Clinical Infectious Diseases · 2020 · 28 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India

Mrinalini Das, Fatima Mamnoon, Homa Mansoor et al. · The International Journal of Tuberculosis and Lung Disease · 2020 · 21 citations · Full text

Medicine, Pediatrics, Pharmacology +17